InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Accardi Mario Alberto, President, Orexin Program. Insider active across 1 companies, notably Centessa Pharmaceuticals plc. Cumulatively, 4 disclosures have been logged. The latest transaction was filed on 8 December 2025 — Levée d'options. Regulator: SEC (Form 4). All data is free.
Declarations4 total
US$40,9365,000 shares@ US$8.18710.0007% mcap54.3% of flow
Ordinary Shares
SEC:0001470831-25-000388·
€40,9365,000 shares@ €8.18710.0007% mcap27.2% of flow
Ordinary Shares
SEC:0001470831-25-000388:0·
US$34,4325,000 shares@ US$6.88640.0006% mcap45.7% of flow
Ordinary Shares
SEC:0001470831-25-000273·
€34,4325,000 shares@ €6.88640.0006% mcap22.8% of flow
Ordinary Shares
SEC:0001470831-25-000273:0·
4 of 4 declarations
About Accardi Mario Alberto
Mario Alberto Accardi is the President of the Orexin Program at Centessa Pharmaceuticals plc. In this role, he is responsible for the strategic and operational direction of the program, aiming to develop innovative treatments. His expertise in the pharmaceutical field is essential for advancing the company's goals and improving patient outcomes.
